Discover the reality of companies and brands!
Free and independant information on large corporations

AstraZeneca Plc

Headquarters : 15 Stanhope Gate London W1Y6LN United Kingdom United Kingdom
Job offers, investor relations : web tel. 44-171-304-5000 email: stock : AZN analytics


click to compare prices
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of AstraZeneca Plc , group and subsidiaries

Jobs -10% /1998 Pollution 2 Fraud 3 Offshore 1 Sales 32 Bn $.€ /year Profit 27 Bn $.€ /1998 Wage 176 *min. Influence 5 Infocom 2
[click on the rating for the method or on the number for the data]

Investor ABSweden3,5Les Echos
» More shareholders of AstraZeneca Plc
2006AstraZeneca is the world's fifth-largest pharmaceutical group.Les Echos
» More business descriptions and market shares for AstraZeneca Plc.
Astra (Pharma) Sweden100
MedImmune, Inc United States of America100Les Echos
Syngenta AG Switzerland39
» More subsidiaries of AstraZeneca Plc
address & contact : production type
incentive source
India India
Bangalore : R&D
 Les Echos
Ireland Ireland
Dublin : R&D
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Les Echos
Mexico Mexico
 Sistema de Informacion de la Industria Maquiladora

  • Human impact

year name
photo position; compensation
2006Schweitzer, Louis
See the photo of: Schweitzer, Louis Chairman of the Board; attendance fee: 0,38 million Eu€;
2004Schweitzer, Louis
See the photo of: Schweitzer, Louis Director;
Les Echos
2003Angelici, Bruno
See the photo of: Angelici, Bruno Executive Vice-President;
2003Barnevik, Percy N
See the photo of: Barnevik, Percy N Chairman;
2003Buchanan, John
See the photo of: Buchanan, John Director;
2003Henney, Jane
See the photo of: Henney, Jane Director;
2003Hooper, Michele
See the photo of: Hooper, Michele Director;
2003Jimenez, Joe
See the photo of: Jimenez, Joe Director;
2003McKillop, Tom
See the photo of: McKillop, Tom Chief Executive Officer;
2003Mogren, Håkan
See the photo of: Mogren, Håkan Chairman;
2003Möller, Erna
See the photo of: Möller, Erna Director;
2003Ogilvie, Dame Bridget
See the photo of: Ogilvie, Dame Bridget Director;
2003Symonds, Jonathan
See the photo of: Symonds, Jonathan Chief Financial Officer;
2003Von der Heyden, Karl
See the photo of: Von der Heyden, Karl Director;
2003Wallenberg, Marcus
See the photo of: Wallenberg, Marcus Director;
1999Bonfield, Peter
See the photo of: Bonfield, Peter Director;
social impact : country
Internal restructuring: AstraZeneca removes 15000 employment before 2013 to save 2,5 billion dollars per year.:
Les Echos
Internal restructuring: AstraZeneca closes its plants in Porrino (Spain), Destelbergen (Belgium) and Umea in Sweden and reduces the production of its plants in Macclesfield, United Kingdom, and Södertälje, Sweden.:
Les Echos
Internal restructuring: AstraZeneca toughens its reorganization plan and finally cuts 10% of its 2006 workforce. AstraZeneca will save more than 656 million euros a year from now to 2010.:
L'usine nouvelle
Internal restructuring: France
Les Echos
Internal restructuring: AstraZeneca cuts 4,6% of its workforce, in spite of 6 billion dollars net profit in 2006.: United States of America
social impact : country
 8 informations, access to subscribers
country : consequences
2005brand: Seroquel : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA)New York Times
1999 : Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers.The Guardian
country : consequences
 2 informations, access to subscribers

  • Subsidy

yearfinancial misdemeanorsalesincome buybacksource
2008   31,66,1   billion US$Les Echos
2006   6   billion US$L'Expansion
2005 Condamné par la Commission Européenne pour pratiques anticoncurrentielles. Le laboratoire a détourné des procédures administratives dans le but de protéger les ventes de son anti-ulcéreux vedette, le Losec (vendu en France sous le nom de Mopral),. A trompé plusieurs offices de brevets nationaux sur la date à laquelle il a reçu sa première autorisation de mise sur le marché, ce qui lui a permis d'obtenir une protection complémentaire dans certains pays. A détourné les règles et procédures appliquées par les agences nationales des médicaments, qui délivrent les autorisations de mise sur le marché. Il a en effet remplacé la présentation d'origine du Losec, en capsules, par des comprimés, en demandant à des agences nationales d'annuler les autorisations de mise sur le marché des premières. Ce qui a pu empêcher des importateurs d'obtenir des licences d'importation, faute d'autorisation de référence. Amende de 60 millions d'euros.     Les Echos
2005   0,6million sharesCercle Finance
2004 Guilty plea by AstraZeneca: collusion among drug companies and doctors to bill government health programs for free samples given as promotions     Bloomberg
2003   18,854,2   billion US$Les Echos
2002   17,842,84   billion US$
2001   16,482,97   billion US$
2000   18,12,54   billion US$
1999   18,451,14   billion US$
1998   9,371,18   billion US$
1996 Defrauded the US healthcare system: gived free samples of cancer drugs to doctors, who then billed Medicare for the full price.     BBC News
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 12 informations, access to subscribers
purpose : intermediary/lobby : institution
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
1999Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translateCorporate Europe Observatory
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 125 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
» More influence from AstraZeneca Plc
» Influence in 2007
purpose : intermediary/lobby : institution
 4 informations, access to subscribers
» More influence from AstraZeneca Plc
» Influence in 2007
dubious practice : image
2007Disinformation: The medical representatives of AstraZeneca incite the doctors to prescribe inexium to replace Mopral, competed with by a generic drug. The Inexium however does not bring any additional therapeutic effectiveness but its refunding by the Social security cost 300 million euros in five years to the policy-holders.: UFC Que Choisir
2004Arguable partnership: Don pour les victimes du tsunami:715 000 euros: value: Humanitaire; AFP

Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010